TipRanks
Meghmani Organics Limited (IN:MOL)
:MOL
India Market
Want to see IN:MOL full AI Analyst Report?

Meghmani Organics Limited (MOL) AI Stock Analysis

3 Followers

Top Page

IN:MOL

Meghmani Organics Limited

(MOL)

Select Model
Select Model
Select Model
Neutral 62 (OpenAI - Gpt-5.6Sol)
Rating:62Neutral
Price Target:
₹60.00
▼(-7.39% Downside)
Action:Reiterated
Date:08/25/26
The score is driven by strong technical momentum (price above key moving averages and positive MACD), partially offset by only moderate financial quality due to volatile results and thin current profitability. Valuation also tempers the score, with a ~25.5 P/E looking less compelling given the earnings and cash-flow variability.
Positive Factors
Diversified Chemical Portfolio
Exposure to both agrochemicals and industrial chemicals gives MOL multiple end markets, including agriculture, textiles, paper, detergents, water treatment and pharmaceuticals. This breadth can reduce dependence on any single customer segment and support manufacturing utilization across cycles.
Negative Factors
Thin Current Margins
Very thin operating and net margins leave limited room to absorb weaker pricing, lower utilization or cost pressure. Even modest adverse changes could materially reduce earnings, making profitability less durable and limiting the cash available for reinvestment or balance-sheet improvement.
Read all positive and negative factors
Positive Factors
Negative Factors
Diversified Chemical Portfolio
Exposure to both agrochemicals and industrial chemicals gives MOL multiple end markets, including agriculture, textiles, paper, detergents, water treatment and pharmaceuticals. This breadth can reduce dependence on any single customer segment and support manufacturing utilization across cycles.
Read all positive factors

Meghmani Organics Limited (MOL) vs. iShares MSCI India ETF (INDA)

Meghmani Organics Limited Business Overview & Revenue Model

Company Description
Meghmani Organics Limited, founded in 1986 and headquartered in Ahmedabad, India, operates as a producer and supplier of an extensive range of pigments and agrochemical products, catering to markets both within India and globally. The company's pi...
How the Company Makes Money
MOL makes money primarily by manufacturing and selling chemicals to domestic and international customers. Its key revenue streams typically include: (1) Agrochemicals: revenue from sales of crop-protection related chemical products, including tech...

Meghmani Organics Limited Financial Statement Overview

Summary
Financials show a 2026 recovery to positive earnings and positive free cash flow, supported by manageable leverage. However, profitability remains thin (low operating and net margins) and results have been volatile across revenues, margins, and free cash flow, limiting confidence in consistency.
Income Statement
56
Neutral
Balance Sheet
62
Positive
Cash Flow
58
Neutral
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue21.03B21.74B21.24B15.48B25.28B24.73B
Gross Profit6.70B5.93B8.60B5.21B4.79B10.01B
EBITDA2.99B2.73B1.87B119.50M4.10B4.81B
Net Income642.50M287.39M-106.01M-1.06B2.38B3.04B
Balance Sheet
Total Assets0.0030.21B30.85B30.40B31.98B27.98B
Cash, Cash Equivalents and Short-Term Investments264.88M264.88M227.24M330.74M1.52B117.22M
Total Debt0.007.26B8.29B8.37B8.24B4.99B
Total Liabilities-15.45B14.76B15.70B15.12B15.29B13.31B
Stockholders Equity15.45B15.45B15.15B15.28B16.69B14.66B
Cash Flow
Free Cash Flow422.76M975.10M-226.88M-165.29M-2.61B-1.79B
Operating Cash Flow668.34M1.43B662.22M2.50B2.04B648.32M
Investing Cash Flow-211.79M-458.42M309.70M-1.78B-4.18B-1.33B
Financing Cash Flow-373.49M-1.04B-913.88M-854.77M2.34B577.19M

Meghmani Organics Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price64.79
Price Trends
50DMA
59.68
Negative
100DMA
54.46
Positive
200DMA
54.31
Positive
Market Momentum
MACD
-1.06
Positive
RSI
35.96
Neutral
STOCH
8.65
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:MOL, the sentiment is Negative. The current price of 64.79 is above the 20-day moving average (MA) of 61.19, above the 50-day MA of 59.68, and above the 200-day MA of 54.31, indicating a neutral trend. The MACD of -1.06 indicates Positive momentum. The RSI at 35.96 is Neutral, neither overbought nor oversold. The STOCH value of 8.65 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:MOL.

Meghmani Organics Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
71
Outperform
₹65.25B10.22―2.11%18.52%49.11%
67
Neutral
₹41.33B15.73―0.21%-5.63%-11.38%
62
Neutral
₹14.30B21.79―1.61%――
58
Neutral
₹454.97B21.60―1.15%12.86%72.26%
56
Neutral
₹349.86B29.11―0.44%-16.57%-27.71%
55
Neutral
$6.65B3.83-15.92%6.20%10.91%7.18%
55
Neutral
₹15.30B13.99―0.57%17.05%9.10%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:MOL
Meghmani Organics Limited
55.44
-29.16
-34.47%
IN:DHANUKA
Dhanuka Agritech Limited
932.65
-602.69
-39.25%
IN:IPL
India Pesticides Ltd.
130.50
-78.47
-37.55%
IN:PIIND
PI Industries Limited
2,245.00
-1,320.62
-37.04%
IN:SHARDACROP
Sharda Cropchem Ltd.
710.30
-91.34
-11.39%
IN:UPL
UPL Limited
522.00
-132.91
-20.29%

Meghmani Organics Limited Corporate Events

Meghmani Organics Announces 7th AGM and E-Voting Arrangements
Aug 15, 2026
Meghmani Organics Limited has notified the stock exchanges that it has published newspaper advertisements announcing its seventh Annual General Meeting for the financial year 2025-26. The AGM will be conducted via video conferencing or other audio...
Exchange Seeks Clarity After Volume Surge in Meghmani Organics
Jul 21, 2026
The stock exchange has flagged a significant increase in trading volume for Meghmani Organics Limited and has formally contacted the company to obtain updated, relevant information. The move aims to ensure transparency, safeguard investor interest...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 25, 2026